Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Lumos Pharma (LUMO) shares
Learn how to easily invest in Lumos Pharma shares.
Lumos Pharma is a biotechnology business based in the US. Lumos Pharma stocks (LUMO.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $11.05 – a decrease of 1.29% over the previous week. Lumos Pharma employs 32 staff and has a trailing 12-month revenue of around $341,000.
How to buy stocks in Lumos Pharma
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LUMO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Lumos Pharma?
- Has coronavirus impacted Lumos Pharma shares?
- Lumos Pharma shares summary
- Compare share dealing platforms
- Is Lumos Pharma stock a buy or sell?
- Lumos Pharma performance over time
- Lumos Pharma's financials
- How volatile are Lumos Pharma shares?
- Does Lumos Pharma pay a dividend?
- Have Lumos Pharma shares ever split?
- Other common questions
Lumos Pharma stock price (NASDAQ:LUMO)Use our graph to track the performance of LUMO stocks over time.
Lumos Pharma shares at a glance
|Latest market close||$7.68|
|52-week range||$6.15 - $12.05|
|50-day moving average||$8.76|
|200-day moving average||$8.83|
|Wall St. target price||$24.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-3.54|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Lumos Pharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Lumos Pharma price performance over time
|1 week (2022-05-18)||0.92%|
|1 month (2022-04-26)||-13.61%|
|3 months (2022-02-24)||-21.79%|
|6 months (2021-11-26)||2.42%|
|1 year (2021-05-27)||-25.29%|
|2 years (2020-05-27)||-48.11%|
|3 years (2019-05-24)||306.35%|
|5 years (2017-05-26)||14.34|
Lumos Pharma financials
|Gross profit TTM||$230,000|
|Return on assets TTM||-17.85%|
|Return on equity TTM||-30.94%|
|Market capitalisation||$66.1 million|
TTM: trailing 12 months
Lumos Pharma share dividends
We're not expecting Lumos Pharma to pay a dividend over the next 12 months.
Have Lumos Pharma's shares ever split?
Lumos Pharma's shares were split on a 1:9 basis on 19 March 2020. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Lumos Pharma shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Lumos Pharma shares which in turn could have impacted Lumos Pharma's share price.
Lumos Pharma share price volatility
Over the last 12 months, Lumos Pharma's shares have ranged in value from as little as $6.15 up to $12.05. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lumos Pharma's is 0.9773. This would suggest that Lumos Pharma's shares are less volatile than average (for this exchange).
Lumos Pharma overview
Lumos Pharma, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas. .
Lumos Pharma in the news
Former White House press secretary Jen Psaki will join MSNBC this fall
Lumos Pharma to Participate in Upcoming Investor Conferences
SEC filings reveal massive selling in media names, including Disney and Comcast
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.Read more…
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.Read more…
Here’s what you need to know about investing in the propane industry, including 3 popular propane stocks to watch.Read more…
More guides on Finder
How to buy Bright Green Corporation stock in Canada
Steps to owning and managing BGXX stock, with 24-hour and historical pricing before you buy.
Apps like Wealthsimple
Learn more about apps like Wealthsimple to find the best trading platform for your unique set of needs.
Online gaming stocks
iGaming is now legal in Ontario. Find out which companies to keep an eye on with our list of 10 top online gaming stocks.
How to buy Entain stock in Canada
Steps to owning and managing ENT stock, with 24-hour and historical pricing before you buy.
How to buy Kambi Group stock in Canada
Steps to owning and managing KAMBI stock, with 24-hour and historical pricing before you buy.
Best brokerage signup bonuses in 2022
Enjoy perks like free trades and cash rewards when you open a stock trading account with these online brokers.
How to buy Rush Street Interactive stock in Canada
Steps to owning and managing RSI stock, with 24-hour and historical pricing before you buy.
How to buy PointsBet stock in Canada
Steps to owning and managing PBTHF stock, with 24-hour and historical pricing before you buy.
How to buy Hanover Bancorp stock in Canada
Steps to owning and managing Hanover Bancorp stocks, with 24-hour and historical pricing before you buy.
How to buy PrimeBlock stock in Canada when it goes public
Everything we know about the PrimeBlock IPO, plus information on how to buy in.